Learning Objectives

  1. Assess the efficacy of mepolizumab in the treatment of eGPA.

  2. Compare two treatment doses of mepolizumab used in the treatment of eGPA.

Session date: 
03/08/2022 - 8:30am to 9:30am CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
John Byun, M.D.